Key Events This Week
15 Sep: New 52-week high of Rs.774 reached intraday
15 Sep: Valuation shifts noted with P/E ratio at 846.58
18 Sep: Week closes at Rs.740.80 (-1.10%)

Broad-Based Technical Strength Lifts Solara Active Pharma Sciences Ltd to 52-Week High of Rs 774
2026-09-15 09:57:22With a decisive break above Rs 774 on 15 Sep 2026, Solara Active Pharma Sciences Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of sustained technical strength across multiple indicators, underscoring the stock’s robust upward trajectory over recent sessions.
Read full news article
Solara Active Pharma Sciences Ltd: Valuation Shifts and Price Attractiveness Analysis
2026-09-15 08:01:14Solara Active Pharma Sciences Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade despite a robust rally in its share price. This transition reflects evolving market perceptions amid strong returns relative to the broader Sensex and peers in the Pharmaceuticals & Biotechnology sector.
Read full news articleSolara Active Pharma Gains 17.04%: 5 Key Events Driving the Surge
2026-09-12 12:01:29
Key Events This Week
7 Sep: Intraday high of Rs.695.85 with an 8.83% surge
8 Sep: New 52-week high at Rs.712
10 Sep: New 52-week highs at Rs.743.05 and Rs.749.45 with strong intraday rallies
11 Sep: New 52-week high at Rs.759.95, closing at Rs.749.05 (+5.82%)

Broad-Based Technical Strength Lifts Solara Active Pharma Sciences Ltd to 52-Week High of Rs 759.95
2026-09-11 15:41:21With a decisive surge to Rs 759.95 on 11 Sep 2026, Solara Active Pharma Sciences Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally comes amid a backdrop of broad technical alignment and outperformance relative to its sector and the broader market.
Read full news article
Broad-Based Technical Strength Lifts Solara Active Pharma Sciences Ltd to 52-Week High of Rs 749.45
2026-09-10 10:45:44With a decisive surge to Rs 749.45 on 10 Sep 2026, Solara Active Pharma Sciences Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals across multiple timeframes, underscoring the stock’s robust upward trajectory despite a broadly subdued market environment.
Read full news article
Solara Active Pharma Sciences Ltd Surges 7.87% to Day's High of Rs 743.05 — Outperforms Sector by 6.97 Percentage Points
2026-09-10 10:32:04While the Sensex edged down marginally by 0.02% on 10 Sep 2026, Solara Active Pharma Sciences Ltd recorded a robust intraday gain of 7.87%, touching a new 52-week high of Rs 743.05. This 6.97 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally in an otherwise subdued market environment.
Read full news article
Solara Active Pharma Sciences Ltd is Rated Hold
2026-09-10 10:10:03Solara Active Pharma Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 10 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleShareholder Meeting / Postal Ballot-Outcome of AGM
18-Sep-2026 | Source : BSESolara Active Pharma Sciences Limited has informed the Exchange regarding the Proceedings of Ninth Annual General Meeting held on September 18 2026.
Intimation In Connection With The Receipt Of Rectification Order
28-Aug-2026 | Source : BSESolara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order
Announcement under Regulation 30 (LODR)-Newspaper Publication
26-Aug-2026 | Source : BSENewspaper publication regarding the completion of dispatch of 9th AGM Notice and Annual report
Corporate Actions
No Upcoming Board Meetings
Solara Active Pharma Sciences Ltd has declared 30% dividend, ex-date: 18 Aug 21
No Splits history available
No Bonus history available
Solara Active Pharma Sciences Ltd has announced 1:3 rights issue, ex-date: 15 May 24







